Jacob Pontoppidan Thyssen

Jacob Pontoppidan Thyssen

Professor, emeritus

Member of:

  • Dermatovenerology


  1. Published

    Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials

    Simpson, E. L., Merola, J. F., Silverberg, J. I., Reich, K., Warren, R. B., Staumont-Sallé, D., Girolomoni, G., Papp, K., de Bruin-Weller, M., Thyssen, Jacob Pontoppidan, Zachariae, R., Olsen, C. K. & Wollenberg, A., 2022, In: British Journal of Dermatology. 187, 6, p. 888-899

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis: Analysis of Follow-up Data From the Measure Up 1 and Measure Up 2 Randomized Clinical Trials

    Simpson, E. L., Papp, K. A., Blauvelt, A., Chu, C. Y., Hong, H. C. H., Katoh, N., Calimlim, B. M., Thyssen, Jacob Pontoppidan, Chiou, A. S., Bissonnette, R., Stein Gold, L. F., Wegzyn, C., Hu, X., Liu, M., Liu, J., Tenorio, A. R., Chu, A. D. & Guttman-Yassky, E., 2022, In: JAMA Dermatology. 158, 4, p. 404-413 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™): a clinical outcome measure for the severity of atopic dermatitis

    Simpson, E. L., Bissonnette, R., Paller, A. S., King, B., Silverberg, J. I., Reich, K., Thyssen, Jacob Pontoppidan, Doll, H., Sun, L., DeLozier, A. M., Nunes, F. P. & Eichenfield, L. F., 2022, In: British Journal of Dermatology. 187, 4, p. 531-538

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial

    Simpson, E. L., Silverberg, J. I., Thyssen, Jacob Pontoppidan, Viguier, M., Thaçi, D., de Bruin-Weller, M., Weidinger, S., Chan, G., DiBonaventura, M., Biswas, P., Feeney, C., Koulias, C. & Cork, M. J., Jul 2023, In: American Journal of Clinical Dermatology. 24, 4, p. 609-621 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Filaggrin loss-of-function mutations and incident cancer: a population-based study

    Skaaby, T., Husemoen, L. L. N., Thyssen, Jacob Pontoppidan, Meldgaard, M., Thuesen, B. H., Pisinger, C., Jørgensen, T., Carlsen, K., Johansen, Jeanne Duus, Menne, Tammes, Szecsi, P. B., Stender, S. & Linneberg, Allan René, Dec 2014, In: British Journal of Dermatology. 171, 6, p. 1407-1414 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Association between atopic dermatitis/eczema and arthritis among US adults

    Smith, B., Engel, P., Collier, M. R., Devjani, S., Thyssen, Jacob Pontoppidan & Wu, J. J., 2023, In: Journal of the European Academy of Dermatology and Venereology. 37, p. e855-e857 3 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  7. Published

    Specific barrier response profiles after experimentally induced skin irritation in vivo

    Soltanipoor, M., Stilla, T., Riethmüller, C., Thyssen, Jacob Pontoppidan, Sluiter, J. K., Rustemeyer, T., Fischer, T. W., Kezic, S. & Angelova-Fischer, I., 2018, In: Contact Dermatitis. 79, 2, p. 59-66 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    High threshold efficacy responses in moderate-to-severe atopic dermatitis are associated with additional quality of life benefits: pooled analyses of abrocitinib monotherapy studies in adults and adolescents

    Stander, S., Bhatia, N., Gooderham, M. J., Silverberg, J., Thyssen, Jacob Pontoppidan, Biswas, P., DiBonaventura, M., Romero, W. & Farooqui, S. A., 6 May 2022, In: Journal of the European Academy of Dermatology and Venereology. 36, 8, p. 1308-1317 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials

    Stein Gold, L., Thaçi, D., Thyssen, Jacob Pontoppidan, Gooderham, M., Laquer, V., Moore, A., Natalie, C. R., Zhao, F., Meskimen, E., Elmaraghy, H., Montmayeur, S., Gallo, G., Jimenez, G. & de Bruin-Weller, M., 2023, In: American Journal of Clinical Dermatology. 24, 4, p. 595-607 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Clinical Relevance of Skin Pain in Atopic Dermatitis

    Ständer, S., Simpson, E. L., Guttman-Yassky, E., Thyssen, Jacob Pontoppidan, Kabashima, K., Ball, S. G., Rueda, M. J., DeLozier, A. M. & Silverberg, J. I., 2020, In: Journal of Drugs in Dermatology. 19, 10, p. 921-926

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 33972183